Sector News

WuXi AppTec to acquire US-based clinical research services firm

May 10, 2019
Chemical Value Chain

WuXi AppTec has announced that has acquired Pharmapace (San Diego, California), a clinical research services company with expertise in providing biometrics services for all phases of clinical trials, regulatory submissions, and post marketing support. Pharmapace will become a wholly owned subsidiary of WuXi Clinical and will continue to focus on growing its core biometrics competences and integrate with WuXi Clinical’s other clinical development services.

Pharmapace, which was founded in 2013, provides a full range of biometrics services for all phases of clinical trials, including clinical and statistical programming, data management, biostatistics, clinical data integration, and medical writing. The acquisition enables WuXi Clinical to expand its biometrics capabilities in the US and Europe. By integrating Pharmapace and WuXi Clinical biometrics teams, WuXi Clinical will be able to provide its customers with efficient and cost-effective biometrics services, the company says.

“This acquisition further enhances WuXi Clinical’s drug development expertise and biometrics capabilities and lays the foundation for the creation of an integrated global biometrics service platform to efficiently and cost-effectively provide customers seamless biometrics services,” says Edward Hu, co-CEO, WuXi AppTec. “Together, we [will be] able to shorten time-to-market of new drugs and to achieve the dream that ‘every drug can be made and every disease can be treated’,” Hu says.

By Michael Ravenscroft

Source: Chemical Week

comments closed

Related News

May 15, 2022

New York’s EPR and packaging reduction bills lauded as game-changers in plastic pollution battle

Chemical Value Chain

The US State of New York is introducing two new bills to combat over-packaging, poor recycling rates and litter issues, including an Extended Producer Responsibility (EPR) program requiring companies such as McDonald’s and Amazon to pay for the cost of packaging disposal and recycling.

May 15, 2022

Borealis and Reclay launch entity focused on lightweight packaging 

Chemical Value Chain

The new organization’s mission is to redesign the critical steps of the plastics sorting and recycling system for post-consumer lightweight packaging (LWP) to speed up circularity, born from a need to meet the rising market demand for high-quality recyclates for use in high-end plastic applications.

May 15, 2022

Starbucks and Hubbub launch reusable packaging fund as COVID-19 diminishes consumer appetite

Chemical Value Chain

Starbucks and Hubbub have launched a £1 million (US$1.22 million) “Bring It Back Fund” to increase the uptake of reusable packaging in the F&B industry. The funding will go toward innovative ideas that make it easier for customers to use alternatives to single-use packaging by supporting pilot projects that help shift consumption habits.